info@thoroughbredbhc.com
Suboxone side effects range from mild nausea in the first weeks to serious dental damage after years of daily use. A 2022 study published in JAMA found that people taking sublingual buprenorphine/naloxone had a 67% higher risk of dental adverse events than those taking oral naltrexone. This article walks through every major side effect category so you can have an informed conversation with your prescriber.
Suboxone Side Effects: What You Need to Know First
Suboxone combines buprenorphine, a partial opioid agonist, with naloxone, an opioid antagonist added mainly to deter injection misuse. When you place the film or tablet under your tongue, naloxone has little systemic effect, while buprenorphine binds opioid receptors strongly enough to reduce cravings and withdrawal without producing the intense euphoria of full agonists like heroin or fentanyl.
That mechanism is why Suboxone works so well. It is also why side effects exist. Any medication that acts on opioid receptors throughout the body can affect the gut, the brain, the endocrine system, and the mouth. Understanding those effects does not mean you should stop taking Suboxone. The FDA prescribing information and every major clinical body agree that the benefits of buprenorphine for opioid use disorder clearly outweigh the risks when the medication is used correctly and monitored over time.
What follows is a plain-language breakdown of short-term, long-term, and withdrawal-related side effects, grounded in peer-reviewed research and official guidance.
Short-Term Side Effects of Suboxone
Most people notice short-term side effects in the first days to weeks of treatment. These tend to improve as your body adjusts.
Common early side effects include:
- Nausea and vomiting, especially if the dose is too high
- Headache
- Sweating and chills
- Constipation
- Dizziness or lightheadedness
- Insomnia or disrupted sleep
- Dry mouth
- Sedation or fatigue
Dry mouth deserves special attention even at this early stage. Saliva buffers acids, remineralizes enamel, and controls bacteria. When saliva decreases, teeth become more vulnerable. This is one reason the dental risks discussed below can begin accumulating from the very first dose.
Sedation is another early concern, particularly if Suboxone is combined with benzodiazepines, alcohol, or other central nervous system depressants. The FDA prescribing information includes warnings about respiratory depression when buprenorphine is taken alongside sedatives, and this risk does not disappear after the first few weeks.
Precipitated withdrawal is a specific short-term risk that occurs when Suboxone is taken too soon after a full opioid agonist. Because buprenorphine has high receptor affinity, it can displace other opioids and trigger sudden, intense withdrawal. This is why induction timing matters and why you should follow your prescriber’s instructions carefully about when to take your first dose.
Long-Term Side Effects of Suboxone
Long-term side effects of Suboxone are less dramatic than acute withdrawal but can be more damaging over time because they develop slowly and may go unnoticed until significant harm has occurred.
Dental Damage: The Clearest Long-Term Risk
The strongest long-term safety signal for Suboxone is dental disease. In January 2022, the FDA warned that buprenorphine medicines dissolved in the mouth had been linked to serious dental problems, including tooth decay, cavities, oral infections, and tooth loss. Some cases occurred in people with no prior history of dental disease.
The mechanism is specific. When you hold a sublingual film or tablet in your mouth for five to ten minutes every day, your teeth are exposed to an acidic formulation for a prolonged period. Over months and years, that acid can erode enamel, weaken teeth, and create conditions where bacteria thrive. Dry mouth compounds the problem by removing saliva’s protective buffering effect.
The JAMA research study by Etminan and colleagues quantified this risk using a database of more than 33,000 patients. People taking sublingual buprenorphine/naloxone experienced dental adverse events at a rate of 21.6 per 1,000 person-years, compared with 10.9 per 1,000 person-years for oral naltrexone users. For the narrower outcome of dental caries or tooth loss specifically, the rate was 8.2 per 1,000 person-years with sublingual buprenorphine/naloxone versus 3.8 with oral naltrexone. The adjusted hazard ratio for caries or tooth loss was 1.71, meaning a 71% higher hazard after adjustment for other factors.
Importantly, the FDA did not recommend stopping buprenorphine. The National Council oral-health guidance states clearly that the benefits of buprenorphine for opioid use disorder outweigh the dental risks when proper precautions are followed. Those precautions are straightforward:
- After the film or tablet fully dissolves, take a large sip of water and gently swish around your teeth and gums
- Wait at least one hour before brushing
- Use fluoride toothpaste and consider a fluoride mouthwash
- Stay hydrated throughout the day
- Tell your dentist you take buprenorphine/naloxone
- Schedule regular dental checkups
The Ophelia oral health guide adds that brushing immediately after dosing can actually worsen enamel damage by scrubbing acid into temporarily softened enamel, which is why the one-hour wait matters.
Hormonal and Endocrine Effects
Buprenorphine is an opioid, and chronic opioid exposure can affect the hypothalamic-pituitary-gonadal and hypothalamic-pituitary-adrenal axes. These are the systems that regulate testosterone, estrogen, cortisol, and other hormones. The FDA prescribing information includes opioid-class warnings about adrenal insufficiency and androgen deficiency with long-term opioid use.
The honest picture is that endocrine disruption is a plausible and clinically important concern, but it is less well-quantified for Suboxone specifically than the dental risk. There is no large Suboxone-specific cohort study measuring hormone levels the way the JAMA study measured dental outcomes. What we do know is that buprenorphine is a partial agonist, which likely makes it less disruptive to hormonal systems than full agonists like methadone, but “less than methadone” is not the same as “none.”
Symptoms that may suggest endocrine problems during long-term Suboxone use include persistent fatigue, low libido, erectile dysfunction, menstrual irregularity, hot flashes, low motivation, and unexplained weight changes. These symptoms overlap heavily with depression, post-acute withdrawal syndrome, poor sleep, and chronic stress, so they are easy to miss or misattribute. If you experience any of these persistently, ask your prescriber about targeted lab work rather than assuming the cause.
Emotional Dulling and Anhedonia
Some people on long-term Suboxone describe feeling emotionally flat. They may notice reduced joy, lower motivation, less interest in relationships or hobbies, or a sense of being calmer but also less alive. This is sometimes called anhedonia, which means a reduced ability to experience pleasure.
A peer-reviewed study measuring emotion through speech detection found that long-term Suboxone patients showed significantly flat affect and less self-awareness of happiness, sadness, and anxiety compared with general-population and Alcoholics Anonymous comparison groups. The authors were careful to note that the study could not distinguish whether flat affect was caused by Suboxone, by opioid use disorder history, by depression, by trauma, or by a combination of these factors.
That caution matters. A review of anhedonia in opioid use disorder found that anhedonia is a key clinical feature of OUD itself, not simply a medication side effect. The brain’s reward system can remain dysregulated for months or years after stopping full opioid agonists. Post-acute withdrawal syndrome, which can include low mood, fatigue, poor concentration, and reduced pleasure, may last well beyond the acute withdrawal phase.
At the same time, buprenorphine may actually improve mood for some people. A systematic review found that buprenorphine shows antidepressant effects in some populations, including people with treatment-resistant depression. One study cited in that review found average depression scores dropped substantially over three months in buprenorphine-maintained patients.
The practical takeaway is that emotional dulling during Suboxone treatment deserves a structured assessment rather than a simple answer. Your prescriber should ask whether your dose is too high, whether sleep is adequate, whether depression or PTSD is untreated, whether other medications are contributing, and whether therapy or behavioral activation might help.
Side Effects of Stopping Suboxone
Stopping Suboxone, whether abruptly or through a taper, produces its own set of side effects. Understanding these is important because the risks of stopping are often underestimated.
What Withdrawal Feels Like
Because buprenorphine has a long half-life of roughly 24 to 42 hours, withdrawal does not begin immediately after the last dose. You may feel relatively normal for the first day or two, then symptoms begin to emerge gradually. A review of buprenorphine detoxification outcomes found that withdrawal often peaks after the dose drops below 2 mg or three to fifteen days after the final dose.
Common withdrawal symptoms include sweating, chills, body aches, restless legs, nausea, diarrhea, insomnia, anxiety, irritability, and intense cravings. The physical symptoms typically improve within one to two weeks, but the psychological phase can last much longer. Post-acute withdrawal syndrome can include low mood, poor sleep, stress sensitivity, and episodic cravings for months after the last dose.
Why Abrupt Stopping Is Dangerous
The danger of stopping Suboxone abruptly is not primarily the withdrawal discomfort itself. The real danger is what happens after. When buprenorphine leaves your system, your opioid tolerance drops. If you return to opioid use at a dose you previously tolerated, that dose may now be enough to cause a fatal overdose.
A large cohort study found that veterans not receiving buprenorphine were more than four times as likely to die by suicide or overdose as those receiving buprenorphine on any given day. Risk was highest eight to fourteen days after discontinuation, with an adjusted hazard ratio of 6.54 compared with current treatment.
A multi-site cohort study of more than 6,500 patients found that mortality after buprenorphine discontinuation was 1.82 per 100 person-years, and that no treatment duration was identified after which stopping appeared clearly safe with respect to all-cause mortality.
A Columbia University summary of a related study found that about 5% of people who stopped buprenorphine after six to eighteen months of treatment required medical care for opioid overdose within the following six months, with the true rate likely higher because overdoses that did not reach healthcare settings were not counted.
Side Effects of Too Much Suboxone
Taking more Suboxone than prescribed can cause sedation, confusion, slowed breathing, pinpoint pupils, and loss of coordination. Because buprenorphine is a partial agonist, it has a ceiling effect for respiratory depression that makes it safer than full agonists at equivalent doses, but that ceiling does not eliminate risk entirely, especially when combined with benzodiazepines, alcohol, or other sedatives. If you or someone you know shows signs of overdose, call emergency services immediately and administer naloxone if available.
Maintenance Versus Stopping: What the Evidence Says
For many people with opioid use disorder, staying on Suboxone long-term produces better outcomes than tapering off. A randomized primary-care trial found that patients assigned to a buprenorphine taper had far worse outcomes than those assigned to maintenance, with only 11% of taper patients completing the trial compared with 66% of maintenance patients.
The Recovery Research Institute reports that both buprenorphine and methadone help reduce illicit opioid use over several years and should remain key treatment options. Long-term treatment is not a sign of weakness or incomplete recovery. For many people, it is the safest path.
If you and your prescriber decide that tapering is the right goal, the safest approach is a slow, flexible, closely monitored reduction over months, with extra caution below 2 mg, naloxone available throughout, and follow-up continuing for months after the final dose. Restarting buprenorphine if cravings return is a safety success, not a failure.
Managing Side Effects: A Practical Summary
| Side effect category | When it appears | Key action |
| Nausea, headache, sweating | First days to weeks | Usually improves; adjust dose timing with prescriber |
| Dental decay and tooth loss | Months to years of use | Rinse after dosing, wait one hour before brushing, see a dentist |
| Hormonal symptoms | Variable; may be gradual | Ask for targeted lab work if symptoms persist |
| Emotional dulling or flat affect | Variable; may overlap with PAWS | Structured assessment of dose, sleep, depression, PTSD |
| Withdrawal on stopping | Days 3 to 15 after last dose | Slow taper, naloxone access, continued follow-up |
| Overdose risk after stopping | Weeks to months after stopping | Keep naloxone, maintain treatment contact, restart if needed |
Why These Side Effects Matter for Your Recovery
Side effects are not a reason to avoid Suboxone. They are a reason to use it thoughtfully, with good monitoring and honest communication with your care team. Dental damage is preventable with a simple rinse-and-wait routine. Hormonal symptoms are treatable when identified early. Emotional dulling often responds to therapy, dose adjustment, or treatment of underlying depression. Withdrawal risks are manageable with a slow, supported taper and naloxone access.
The goal is not to minimize medication at all costs. The goal is to stay alive, stable, and free from compulsive opioid use. For most people with opioid use disorder, Suboxone is a tool that makes that goal achievable. Understanding its side effects helps you use that tool safely.
If you are navigating Suboxone treatment, managing withdrawal, or dealing with co-occurring depression or trauma alongside opioid use disorder, speaking with a specialized treatment team can make a real difference. Reach out to Thoroughbred Wellness and Recovery to learn how medical detox and dual diagnosis programs can support your recovery.
Give Us A Call 
